1. PRODUCT OVERVIEW
Ipamorelin is a synthetic peptide belonging to the class of Ghrelin receptor agonists. It was developed as a selective growth hormone secretagogue and is widely used in scientific research to investigate the regulation of growth hormone release.
Due to its receptor selectivity, ipamorelin is commonly applied as a research tool for studying endocrine signaling pathways, receptor interactions, and mechanisms associated with growth hormone regulation and metabolic processes.
2. STORAGE & HANDLING PROTOCOL
Long-term Storage: Maintain the lyophilized powder at -20°C (-4°F). Ensure the vial remains sealed and protected from light.
Post-Reconstitution: Reconstitute with sterile diluent. Store the resulting solution at 2–8°C (36–46°F).
Stability: For maximum experimental integrity, utilize the reconstituted product within 30 days. Avoid vigorous mechanical agitation.
3. POTENTIAL RESEARCH APPLICATIONS
This compound is intended for the following areas of laboratory study:
Secretagogue Mechanisms: Investigating the activation of ghrelin receptors and their role in growth hormone secretion.
Endocrine Signaling: Evaluating receptor-mediated pathways and cellular responses to selective stimulation.
Receptor Selectivity: Studying the interaction of growth hormone secretagogues with specific signaling systems.
Metabolic Regulation: Researching the involvement of endocrine pathways in systemic metabolic homeostasis and regulation.
4. REGULATORY DISCLAIMER
NOTICE: This product is supplied strictly FOR LABORATORY RESEARCH and development purposes. It is NOT FOR HUMAN CONSUMPTION, therapeutic, or diagnostic use. This material must be handled by qualified scientific professionals in a controlled environment.
5. REFERENCES
- Ipamorelin, the first selective growth hormone secretagogue
https://pubmed.ncbi.nlm.nih.gov/9849822/ - Ipamorelin, a new growth-hormone-releasing peptide with distinct and specific properties
https://pubmed.ncbi.nlm.nih.gov/10373343/ - Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers
https://pubmed.ncbi.nlm.nih.gov/10496658/ - The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
https://pubmed.ncbi.nlm.nih.gov/11735244/ - Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model
https://pmc.ncbi.nlm.nih.gov/articles/PMC4863553/
Reviews
There are no reviews yet.